<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.4" extension="2015-08-01"/>
  <id root="eb4db2cd-cd4f-424f-8b66-8700a79c4f84"/>
  <code code="11488-4" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Consult note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Vascular Surgery Consultation — Ella Fitzgerald</title>
  <effectiveTime value="20260526120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="c3b2f6b6-4fc1-4d58-a9ad-62e14ddef852"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="a87d5a88-726b-4149-b058-8a69daa31b19" extension="HR-ML029-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-29-3640"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Ella</given><family>Fitzgerald</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19560425"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260526120000-0500"/>
    <assignedAuthor><id root="6ad86aa8-2c16-44e4-9e2e-ccde85cf68e0"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Marcus</given><family>Okafor-Lane</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260526120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="6ad86aa8-2c16-44e4-9e2e-ccde85cf68e0"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Marcus</given><family>Okafor-Lane</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <inFulfillmentOf>
    <order><id root="46f256f6-d8e1-4141-99c9-f2af2dcf580b"/></order>
  </inFulfillmentOf>
  <documentationOf>
    <serviceEvent classCode="PCPR"><effectiveTime><low value="20260526"/><high value="20260526"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="6ad86aa8-2c16-44e4-9e2e-ccde85cf68e0"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Marcus</given><family>Okafor-Lane</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="d07bc058-684e-4a9d-a592-b4bfda2ad1b9"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Two-week review: glucose and hypoglycemia safety on the new plan, and vascular surgery consultation</originalText></code>
      <effectiveTime><low value="20260526"/><high value="20260526"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="6ad86aa8-2c16-44e4-9e2e-ccde85cf68e0"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Marcus</given><family>Okafor-Lane</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.1" extension="2014-06-09"/>
    <code code="42349-1" codeSystem="2.16.840.1.113883.6.1" displayName="Reason for referral (narrative)"/>
    <title>Reason for Referral</title>
    <text><paragraph>Claudication of both calves, worse on the right, in a 70-year-old touring singer with type 2 diabetes, coronary bypass surgery last year, and an ankle-brachial index of 0.62 right and 0.74 left. Please define the arterial disease, advise on exercise and antithrombotic therapy, and tell us whether and when revascularization should be considered, so that her limbs are protected before any tissue is lost. [S]</paragraph><paragraph>Urgency: Within two to three weeks, on the same day as her two-week primary care visit. [S]</paragraph><paragraph>Questions for the consultant:</paragraph><list listType="ordered"><item>Where is the arterial disease, and how severe is it?</item><item>Is supervised exercise therapy appropriate, and how should it fit around her touring?</item><item>Should antithrombotic therapy change, for example low-dose rivaroxaban with aspirin?</item><item>Is revascularization indicated now, and what would make it indicated later?</item><item>How often should her arteries and feet be reviewed, and what findings need urgent vascular review?</item></list></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. Fitzgerald, a 70-year-old singer, is seen at the request of Dr. Whitlow for calf pain on walking. For about a year both calves have cramped after one and a half blocks, the right sooner, easing within minutes of rest; she uses a wheelchair in large airports. She has no pain at rest or at night, no wounds, and no color change. She had five-vessel coronary bypass surgery last year and has no angina. She has diabetes with retinopathy and has never smoked. She has had no bleeding problems. She stands through long sets on stage and wants to keep touring. [S]</paragraph><paragraph>Historical basis. These claims are historical evidence, not findings from a modern examination.</paragraph><list><item>Ella Jane Fitzgerald was born on April 25, 1917, in Newport News, Virginia, to Temperance and William Fitzgerald. Most biographies gave 1918, but her birth certificate and school records show 1917. [D]</item><item>In 1932 her mother died suddenly of a heart attack; orphaned at 15, she was placed in the Colored Orphan Asylum in Riverdale, New York. [D]</item><item>In 1934 she won an amateur contest at the Apollo Theater in Harlem, which brought her to the attention of the drummer and bandleader Chick Webb; she made her first recording with his band in 1935, and her 1938 swing version of the nursery rhyme &quot;A-Tisket, A-Tasket&quot; became her first hit. [D]</item><item>She won the Grammy Award for Best Jazz Individual Performance in 1958 for Ella Fitzgerald Sings the Duke Ellington Song Book, and received the Kennedy Center award for lifetime achievement in 1979. She was known as America&apos;s first lady of song. [D]</item><item>She began to have health problems during the 1970s; she had diabetes, which caused problems with her eyes. [D]</item><item>In the 1970s, after cataract surgery, she returned to touring more than 40 weeks a year. [D]</item><item>In 1986 she was admitted to intensive care for heart trouble and underwent quintuple-bypass heart surgery; the following year she was back onstage. [D]</item></list><paragraph>6 later historical claims are omitted because they describe events after the index age. See the teaching note.</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="090bf46c-bcfd-4d57-87db-d967d5a84ba3"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260511"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="5ec2e7c2-ee03-4ab4-8f05-122f556ce9db"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Metformin 1000 mg oral tablet, one tablet by mouth twice daily with meals</td><td>One tablet by mouth twice daily with breakfast and the evening meal</td><td>Oral route</td><td>2016-03-01</td><td>active</td><td>S</td></tr><tr ID="medication-2"><td>Glipizide 10 mg oral tablet, one tablet by mouth twice daily before meals</td><td>One tablet by mouth twice daily before breakfast and the evening meal</td><td>Oral route</td><td>2021-09-01 to 2026-05-11</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Insulin glargine 100 units/mL pen, 30 units under the skin at bedtime</td><td>30 units at bedtime</td><td>Subcutaneous route</td><td>2023-04-01 to 2026-05-11</td><td>completed</td><td>S</td></tr><tr ID="medication-4"><td>Insulin glargine 100 units/mL pen, 24 units under the skin each morning</td><td>24 units each morning, at the same clock time on tour, with written time-zone adjustments</td><td>Subcutaneous route</td><td>2026-05-11</td><td>active</td><td>S</td></tr><tr ID="medication-5"><td>Atorvastatin 40 mg oral tablet, one tablet by mouth daily</td><td>One tablet by mouth daily</td><td>Oral route</td><td>2025-06-02 to 2026-05-11</td><td>completed</td><td>S</td></tr><tr ID="medication-6"><td>Atorvastatin 80 mg oral tablet, one tablet by mouth daily</td><td>One tablet by mouth daily</td><td>Oral route</td><td>2026-05-11</td><td>active</td><td>S</td></tr><tr ID="medication-7"><td>Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily</td><td>One tablet by mouth daily</td><td>Oral route</td><td>2025-06-02</td><td>active</td><td>S</td></tr><tr ID="medication-8"><td>Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth daily</td><td>One tablet by mouth daily</td><td>Oral route</td><td>2025-06-02</td><td>active</td><td>S</td></tr><tr ID="medication-9"><td>Empagliflozin 10 mg oral tablet, one tablet by mouth each morning</td><td>One tablet by mouth each morning; hold on days she cannot eat or drink normally and before surgery</td><td>Oral route</td><td>2026-05-11</td><td>active</td><td>S</td></tr><tr ID="medication-10"><td>Glucagon 3 mg nasal powder, one spray into one nostril for a severe low glucose</td><td>One spray into one nostril if she cannot safely swallow during a low glucose; may repeat once after 15 minutes with a new device; call 911</td><td>Nasal route</td><td>2026-05-11</td><td>active</td><td>S</td></tr><tr ID="medication-11"><td>Rivaroxaban 2.5 mg oral tablet, one tablet by mouth twice daily with aspirin 81 mg</td><td>One tablet by mouth twice daily, with aspirin 81 mg once daily</td><td>Oral route</td><td>2026-05-26</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="4b26143e-288f-42fe-a35b-291515342369"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20160301"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="12" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="861004" codeSystem="2.16.840.1.113883.6.88" displayName="metformin hydrochloride 1000 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="eb38b151-2d87-4cf1-9bfd-da3a5ebda59a"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="0aad3558-f4d0-4e3c-851d-73cc3eac3ed7"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20210901"/><high value="20260511"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="12" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="310488" codeSystem="2.16.840.1.113883.6.88" displayName="glipizide 10 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="8d0c37d3-4add-4506-a0bd-972b7cc1ea79"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="26a6b04d-8c1b-4483-82c4-6530ab1c2f61"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20230401"/><high value="20260511"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Subcutaneous route"/>
      <doseQuantity value="30" unit="[IU]"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="847230" codeSystem="2.16.840.1.113883.6.88" displayName="3 ML insulin glargine 100 UNT/ML Pen Injector"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="e01e8d4f-f96b-4250-bec0-8bcde89bb958"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="075ddc8a-51f8-4221-a2a5-b26403af1fe7"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260511"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Subcutaneous route"/>
      <doseQuantity value="24" unit="[IU]"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="847230" codeSystem="2.16.840.1.113883.6.88" displayName="3 ML insulin glargine 100 UNT/ML Pen Injector"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="fbdd7a61-39a8-4fae-87ad-8515cc958b49"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="e25dc7fd-067a-484d-b726-5e1c7f797b2e"/>
      <text><reference value="#medication-5"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20250602"/><high value="20260511"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="617311" codeSystem="2.16.840.1.113883.6.88" displayName="atorvastatin 40 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="9b9ba92a-f027-44e0-9be1-282fde3c62a2"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="ca957e1f-e199-4cb4-849b-9fa7481bc9fc"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="b29d2b2c-85b2-45fb-96e3-2e1f7b663001"/>
      <text><reference value="#medication-6"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260511"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="259255" codeSystem="2.16.840.1.113883.6.88" displayName="atorvastatin 80 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="a909b55d-7422-42c4-8e05-27c3415230ec"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="f80bfa8a-19fd-4fa1-94cd-88c3fdcd83d5"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="c95dda93-64f9-4682-8322-0c5f4eb1ac9b"/>
      <text><reference value="#medication-7"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20250602"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="308416" codeSystem="2.16.840.1.113883.6.88" displayName="aspirin 81 MG Delayed Release Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="e4214ffc-a800-41e3-966d-ffe59cea5e1f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="962a3085-cddc-4260-bfac-35cbc3cf70d5"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="58d6b2af-99f9-4a98-92ed-2b40b79e194c"/>
      <text><reference value="#medication-8"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20250602"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="866427" codeSystem="2.16.840.1.113883.6.88" displayName="metoprolol succinate 25 MG 24HR Extended Release Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="d7e15ee8-be43-401a-b14b-3aa371c7759d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="378fde12-bae9-4c70-b9d8-023bb770f500"/>
      <text><reference value="#medication-9"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260511"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1545658" codeSystem="2.16.840.1.113883.6.88" displayName="empagliflozin 10 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="7b44054e-9d15-4950-8cdc-e33e0e775e6a"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="699c3ba4-d726-420a-af1e-b089eac9025c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="c6dfdba1-f74c-4cd2-bda0-323471b63c1f"/>
      <text><reference value="#medication-10"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260511"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="15" unit="min"/></effectiveTime>
      <routeCode code="C38284" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Nasal route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="2180666" codeSystem="2.16.840.1.113883.6.88" displayName="glucagon 3 MG Nasal Powder"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="06202602-4da2-47b3-85c0-851f69f902af"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="b1db6fdb-4009-4cc3-814e-efdc64550f20"/>
      <text><reference value="#medication-11"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260526"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="12" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="2059015" codeSystem="2.16.840.1.113883.6.88" displayName="rivaroxaban 2.5 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="505e9d46-79b6-466b-9dd4-f6bdd1afaeea"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="5aeb8d53-4dc1-471b-998a-8ed637a42e7f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Type 2 diabetes mellitus with peripheral artery disease: cramping in both calves after about one and a half blocks of walking, worse on the right, easing within minutes of rest; no rest pain, wounds, or color change. Resting ankle-brachial index 0.62 right and 0.74 left, toe-brachial index 0.46 and 0.55; dorsalis pedis and posterior tibial pulses absent on the right and faint on the left. A1c 8.6% on metformin, glipizide and glargine, with low glucose readings (to 52 mg/dL) after late performances. Foot: protective sensation intact to the 10-g monofilament at all sites and to vibration; callus under the second metatarsal heads; hammer toes of the second and third toes; no ulcer (IWGDF risk category 2). Synthetic modern episode linked to her documented diabetes and its circulatory complications</td><td>active</td><td>confirmed</td>
    <td>E11.51</td><td>S — Synthetic modern diagnosis; the type of diabetes was not made public and is synthetic.</td>
  </tr>
  <tr ID="problem-2">
    <td>Moderate nonproliferative diabetic retinopathy with center-involving diabetic macular edema in the right eye (best-corrected acuity 64 letters, about 20/50) and moderate nonproliferative retinopathy without macular edema in the left eye (81 letters); lens implants in both eyes from earlier cataract surgery. Synthetic modern episode linked to her documented diabetic eye problems</td><td>active</td><td>confirmed</td>
    <td>E11.3311</td><td>S — Synthetic modern eye diagnosis on retinal imaging and optical coherence tomography in the clinic; the left eye is described in the display.</td>
  </tr>
  <tr ID="problem-3">
    <td>Coronary artery disease after five-vessel coronary bypass surgery last year, with an intensive care stay; no angina now; on aspirin, a statin, and metoprolol. Synthetic modern episode linked to her documented heart surgery</td><td>active</td><td>confirmed</td>
    <td>I25.10</td><td>S — Synthetic modern coding of her documented heart surgery; bypass grafts are described in the display.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="5b0461d3-b82c-4fff-b2aa-ff31d4cea825"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260511"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="e0d8b117-7cdf-4010-a5bf-8e651e560d13"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260511"/></effectiveTime>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="4cce2fc3-9404-4542-98db-1ad48a7b27ba"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260511"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="dc85bf27-121a-4eb1-9a13-97c6495eb11c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260511"/></effectiveTime>
          <value xsi:type="CD" code="E11.3311" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="1a7b2058-87aa-4d77-af33-b962bf5717b3"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260511"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="cfdb83a3-730d-43f4-8156-fc9e5585167a"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260511"/></effectiveTime>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-05-26; see the referring visit&apos;s Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>Vascular</td><td>Femoral pulses present and equal; popliteal and foot pulses absent on the right; foot pulses faint on the left; no bruits over the abdomen</td></tr><tr><td>Feet</td><td>Warm; slow capillary refill on the right; no pallor on elevation or dependent rubor; skin intact; calluses and hammer toes; no ulcer or gangrene</td></tr><tr><td>Neurological</td><td>Protective sensation intact to the monofilament</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section nullFlavor="NI">
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1"/>
    <title>Results</title>
    <text><paragraph>No results recorded at this visit.</paragraph></text>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.8"/>
    <code code="51848-0" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation note"/>
    <title>Assessment</title>
    <text><list listType="ordered"><item>Type 2 diabetes with peripheral artery disease (E11.51). Femoropopliteal peripheral artery disease in both legs: a right superficial femoral artery occlusion and a moderate left superficial femoral artery stenosis, with good flow to the feet. She has lifestyle-limiting claudication without signs of chronic limb-threatening ischemia (no rest pain, wound, or gangrene), so the limb is not at immediate risk. The first steps are supervised exercise therapy and medical therapy, which improve walking and lower the risk of heart attack, stroke, and limb events. Revascularization is considered when claudication still limits her life after a trial of exercise and medicines, and urgently if a wound, rest pain, or color change appears. Because amputation is more common in people with diabetes, and more common still, and more often done without a vascular assessment first, in Black Americans and in people with less access to care, she should have a low threshold for prompt vascular review of any foot problem. [S]</item><item>Coronary artery disease after bypass surgery (I25.10). Disease in two vascular beds. Low-dose rivaroxaban with aspirin lowers the risk of major cardiovascular and limb events in symptomatic peripheral artery disease, and her bleeding risk is low (no earlier bleeding, normal hemoglobin and kidney function, no anti-inflammatory painkillers). [S]</item></list><paragraph>Data reviewed: Dr. Whitlow&apos;s intake note and today&apos;s two-week note. Ankle-brachial index 0.62 right and 0.74 left; toe-brachial index 0.46 and 0.55. Creatinine 0.92 mg/dL, eGFR 67; hemoglobin 12.4 g/dL; LDL 92 mg/dL; A1c 8.6%. Arterial duplex in the vascular laboratory today: aortoiliac and common femoral arteries without significant narrowing; right superficial femoral artery occluded for about 9 cm in its middle third, with flow restored in the above-knee popliteal artery and two open tibial arteries to the foot; left superficial femoral artery narrowed by 50 to 69% with an open popliteal artery and three tibial arteries; calcified tibial arteries on both sides. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.10" extension="2014-06-09"/>
    <code code="18776-5" codeSystem="2.16.840.1.113883.6.1" displayName="Plan of care note"/>
    <title>Plan of Treatment</title>
    <text><list><item>No revascularization now. [S]</item><item>Supervised exercise therapy: treadmill walking to moderate calf pain, 30 to 45 minutes three times a week for twelve weeks, with a structured home walking plan for tour weeks. [S]</item><item>Start rivaroxaban 2.5 mg twice daily with aspirin 81 mg daily; avoid anti-inflammatory painkillers. [S]</item><item>Continue atorvastatin 80 mg and add ezetimibe if LDL stays at 55 mg/dL or above; a GLP-1 receptor agonist such as semaglutide, which increased walking distance in people with peripheral artery disease and type 2 diabetes, is worth considering when her glucose plan is reviewed. [S]</item><item>Reassess after twelve weeks of exercise; if claudication still limits her life, consider endovascular treatment of the right superficial femoral artery. [S]</item><item>Urgent vascular review, the same or next day, for rest pain, a foot wound that does not heal within two weeks, or a cold, pale, or dark toe. [S]</item><item>Vascular review with ankle-brachial index and duplex in six months, and yearly after that if stable. [S]</item><item>High-risk foot program with podiatry every three months and protective, low-heeled shoes on and off stage. [S]</item><item>Discussed with Dr. Whitlow, who saw her the same day. The findings and choices were explained to Ms. Fitzgerald, who chose to begin supervised exercise and rivaroxaban; she decides who else receives this note. [S]</item><item>Follow-up: Message review with Dr. Whitlow after twelve weeks of supervised exercise; vascular clinic in six months with ankle-brachial index and duplex; sooner for any of the urgent signs. [S]</item></list></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
